[Antibodies and physiopathogeny of autoimmune hepatitis].

Rev Invest Clin

Departamento de Gastroenterología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán.

Published: March 2004

Autoimmune hepatitis (AIH) is an inflammatory disease of unknown cause characterized by periportal hepatitis, increased serum globulins and the presence of certain antibodies. The disorder can be classified in three types. Type 1 AIH is characterized by the presence of antinuclear antibodies (ANA) and smooth muscle autoantibodies (SMA) in up to 70-80% of patients. ANA and SMA can be the only antibodies present in 13 and 33% of cases respectively. Type 2 AIH is defined by the presence of liver and kidney antimicrosomal antibodies (LKM1). Type 2 AIH is the only form of the disease in which the autoantigen has been identified: cytochrome mono-oxygenase (P-450 IID6) CYP2D6. In type 3 AIH the presence of anti-SLA/LP (soluble liver antigen/liver pancreas) targets a cytosolic protein involved in the incorporation of selenocysteine into peptidic chains. The pathophysiology of AIH is complex and involves genetic predisposition, previous exposure to antigens (autoantigens), presence of triggering factors and defects in immunoregulation. In spite of the advances in the understanding of AIH, the role of autoantibodies in the pathophysiology of this disease has not been fully established and their presence does not clearly distinguish any prognostic groups. Further investigations will help in the diagnosis of this disorder, the comprehension of its origins and the establishment of new forms of treatment.

Download full-text PDF

Source

Publication Analysis

Top Keywords

type aih
16
aih
7
presence
6
[antibodies physiopathogeny
4
physiopathogeny autoimmune
4
autoimmune hepatitis]
4
hepatitis] autoimmune
4
autoimmune hepatitis
4
hepatitis aih
4
aih inflammatory
4

Similar Publications

A genome-wide cross-trait analysis identifying shared genetic basis and causal relationships between Hunner-type interstitial cystitis and autoimmune diseases in East Asian populations.

Front Immunol

December 2024

Department of Urology, Lab of Health Data Science, Innovation Institute for Integration of Medicine and Engineering, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Article Synopsis
  • The study explores the genetic connections between Hunner interstitial cystitis (HIC) and autoimmune diseases (ADs), suggesting they may share common genetic factors.
  • Utilizing a large East Asian population, the researchers employed advanced statistical methods like Mendelian randomization to assess causal relationships and identify genetic markers linked to both conditions.
  • Results showed causal effects of certain autoimmune conditions on HIC and vice versa, along with insights into genetic variants affecting gene expression in autoimmune-related tissues, highlighting a potential shared genetic basis for these diseases.
View Article and Find Full Text PDF

IFITM1 aggravates ConA-Induced autoimmune hepatitis by promoting NKT cell activation through increased AMPK-Dependent mitochondrial function.

Int Immunopharmacol

January 2025

Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing 10020, China; Department of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. Electronic address:

Although interferon-induced transmembrane 1 (IFITM1) is known for its crucial role in antiviral immunity, its involvement in autoimmune hepatitis (AIH) remains largely unexplored. In this study, we observed that IFITM1 expression is markedly upregulated in a Concanavalin A (ConA)-induced AIH model, with particularly high and markedly elevated expression in natural killer T (NKT) cells. To further understand the role of IFITM1, we examined the responses of IFITM1 mice in a model of ConA-induced liver injury.

View Article and Find Full Text PDF

Acute intermittent hypoxia elicits sympathetic neuroplasticity independent of peripheral chemoreflex activation and spinal cord tissue hypoxia in a rodent model of high-thoracic spinal cord injury.

Exp Neurol

February 2025

International Collaboration on Repair Discoveries, University of British Columbia, Vancouver, BC, Canada; Centre for Chronic Disease Prevention and Management, University of British Columbia, Kelowna, BC, Canada; Department of Cellular and Physiological Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. Electronic address:

Article Synopsis
  • The study investigates how spinal cord injury (SCI) impacts the body's ability to control heart and blood vessels, leading to cardiovascular diseases (CVD) due to loss of medullary control.
  • It explores acute intermittent hypoxia (AIH) as a potential treatment to stimulate sympathetic nerve activity and promote neuroplastic changes called long-term facilitation (LTF) in the sympathetic circuits after SCI.
  • Results show that a single session of AIH can effectively boost sympathetic nerve activity in a rat model of SCI, opening possibilities for chronic AIH treatment to manage complications from sympathetic hypoactivity.
View Article and Find Full Text PDF

We herein report a case of IgG4-related autoimmune hepatitis (AIH) in a patient with a history of type 1 autoimmune pancreatitis. A 56-year-old man presented with fatigue and jaundice at our hospital. A blood biochemistry analysis revealed significant liver dysfunction, positive results for antinuclear antibodies, and high serum IgG4 levels.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigated the relationship between sleep apnea syndrome (SAS) and the dosage/timing of opioid substitution treatments (OST) in patients using methadone or buprenorphine for opioid use disorder.
  • It included a retrospective analysis of adult patients who received these treatments over several years, assessing their apnea-hypopnea index (AHI) alongside treatment data.
  • The findings indicated that higher doses of methadone, particularly taken in the evening, were linked to more severe SAS, while no significant association was found between buprenorphine doses and AHI, suggesting buprenorphine might be a better alternative for patients with SAS.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!